Type IV P-type ATPases (P4-ATPases) translocate phospholipids from the exoplasmic to the cytoplasmic leaflets of cellular membranes. We and others previously showed that ATP11C, a member of P4-ATPases, translocates phosphatidylserine (PS) at the plasma membrane. Twenty years ago, the UPS-1 (uptake of fluorescent PS analogs) cell line was isolated from mutagenized Chinese hamster ovary (CHO)-K1 cells with a defect in non-endocytic uptake of NBD-PS. Due to its defect in PS uptake, the UPS-1 cell line has been used in an assay for PS-flipping activity; however, the gene(s) responsible for the defect have not been identified to date. Here, we found that the mRNA level of ATP11C was dramatically reduced in UPS-1 cells relative to parental CHO-K1 cells. By contrast, the level of ATP11A, another PS-flipping P4-ATPase at the plasma membrane, or CDC50A, which is essential for delivery of most P4-ATPases to the plasma membrane, was not affected in UPS-1 cells. Importantly, we identified a nonsense mutation in the ATP11C gene in UPS-1 cells, indicating that the intact ATP11C protein is not expressed.
Introduction
The lipid bilayers of cellular membranes exhibit asymmetric lipid distributions. In the plasma membrane, the aminophospholipids, phosphatidylserine (PS) and phosphatidylethanolamine (PE), are abundant in the cytoplasmic leaflet, whereas phosphatidylcholine (PC) and sphingomyelin (SM) are enriched in the exoplasmic leaflet. Type IV P-type ATPases (P4-ATPases) are essential for generation and maintenance of phospholipid asymmetry in lipid bilayers (1, 2) . Regulated exposure of PS in the exoplasmic leaflet is critical for certain biological processes, including apoptotic cell death, platelet coagulation, and fusion of muscle cells, (3) (4) (5) illustrating the importance of lipid asymmetry at steady state. Most mammalian and yeast P4-ATPases must associate with CDC50 family proteins in order to exit the endoplasmic reticulum (ER) and reach their appropriate subcellular destinations (6) (7) (8) (9) (10) (11) (12) . We recently showed that the human P4-ATPases, ATP11A, and ATP11C, flip NBD-labeled PS (NBD-PS) and NBD-PE, whereas ATP8B1, ATP8B2, and ATP10A flip NBD-PC specifically at the plasma membrane (13, 14) . Phospholipid asymmetry regulated by P4-ATPases is indispensable for homeostasis of multicellular organisms. Mutations in the human FIC1/ATP8B1 gene cause progressive familial intrahepatic cholestasis (PFIC) (15, 16) . Some ATP8B1 mutants found in type 1 PFIC fail to flip PC, indicating that PC-flipping activity at the bile canaliculi is critical for proper bile excretion in liver (13) . ATP11C deficiency causes a defect in B-cell maturation, altered erythrocyte shape, and anemia (17, 18) . Moreover, ATP11C undergoes caspase-mediated cleavage and is consequently inactivated, resulting in PS exposure on the cell surface during apoptosis (19) .
UPS-1 (uptake of fluorescent PS analogs) cells were isolated by screening mutants of CHO-K1 cells defective in non-endocytic uptake of NBD-PS (20) , and have been widely used in an assay for PS-flipping activity due to their defect in PS uptake (8, 9, 16, 21, 22) . However, the gene(s)
responsible for the defect have not been previously identified. In this study, we found that the expression level of ATP11C mRNA was substantially decreased in UPS-1 cells, whereas the level of ATP11A or CDC50A mRNA was not affected. Importantly, we found a nonsense mutation in the ATP11C gene in UPS-1 cells. We further demonstrated that uptake of PS was restored upon exogenous expression of ATP11C in UPS-1 cells. These results indicate that the defect in PS uptake in UPS-1 cells is ascribed to the lack of the functional ATP11C protein.
Materials and Methods
Plasmids. P4-ATPase cDNAs were cloned separately into the pENTR3C vector (Invitrogen), as described previously (12) .
RT-PCR and quantitative RT-PCR (qRT-PCR).
Total RNA was isolated from CHO or UPS-1 cells using Isogen (Nippon Gene) or RNeasy Mini Kit (Qiagen), and then subjected to RT-PCR analysis 5 using the SuperScript III One-Step RT-PCR system (Invitrogen). For qRT-PCR, total RNA was subjected to reverse transcription using a SuperScript VILO cDNA Synthesis Kit (Invitrogen). The resultant cDNA was used as a template for PCR using LightCycler FastStart DNA MasterPLUS SYBR Green I (Roche Applied Science); fold changes in gene expression were normalized to the -actin mRNA level. Chinese hamster ATP11C cDNA was amplified using the following primer pairs: set 1
antisense, 5'-CTGATAAATATGAGGAGAATTATGG-3') and set 3 (3'UTR; sense, 5'-GTATAGGGTTCAGAATAAATGTCC-3'; antisense, 5'-GATATTAGACCAAGACAATTAGTC-3').
The ATP11A, CDC50A, and-actin cDNAs were amplified using the primer pairs (sense, 5'-CATGGAAGTGCTCAAGAGAGAC-3'; antisense, 5'-GAGCAGGCTGACAGTGACAAG-3'), were excluded from the analysis.
Results and Discussion
A nonsense mutation is found in ATP11C gene in UPS-1 cells.
UPS-1, a mutant cell line of CHO-K1 (hereafter CHO), is defective in non-endocytic uptake of NBD-PS (20) . Prior to the experiments described below, we confirmed that the uptake of NBD-PS is defective in UPS-1 cells. To this end, we assayed the flippase activities by incubating CHO and UPS-1 cells in the presence of NBD-PS, -PE, -PC, or -SM at 15°C, followed by extraction with fatty acid-free BSA of fluorescent phospholipids that were unincorporated or retained in the exoplasmic leaflet of the plasma membrane. As shown in Figure 1A and B, uptake of NBD-PS was lower in UPS-1 cells than in parental CHO cells, whereas uptake of NBD-PE, -PC, or -SM did not change. These results are consistent with those of an original report (20) .
We recently elucidated flippase activities and substrate specificities of the plasma membrane-localized human P4-ATPases, ATP8B1, ATP8B2, ATP10A, ATP11A, and ATP11C, using NBD-labeled phospholipids. ATP11A and ATP11C translocate NBD-aminophospholipids (PS and PE), whereas ATP8B1, ATP8B2, and ATP10A preferentially flip NBD-PC (13, 14) . We also previously showed that CDC50A is required for the plasma membrane localization of
ATP11A and ATP11C (12). Knockdown by RNAi or CRISPR/Cas9 knockout of CDC50A dramatically decreases PS-flipping activity in several cell types (our unpublished data) (19).
Moreover, ATP11C deficiency also decreases PS-flipping activity (17) (18) (19) . Therefore, we hypothesized that the defect in the uptake of PS in UPS-1 cells might result from a defect in plasma membrane-localizing PS-flipping P4-ATPases (ATP11A and ATP11C) or a defect in CDC50A, which is required for delivery of P4-ATPases to the plasma membrane. To examine this hypothesis, we firstly performed RT-PCR to measure the mRNA levels of ATP11A, ATP11C, and CDC50A in CHO and UPS-1 cells (Figure 2A ). All primer sets were designed to include at least one predicted intron to avoid amplification from genomic DNA. As shown in Figure 2A , the mRNA level of ATP11C was substantially lower in UPS-1 cells (U) than in CHO cells (C). We confirmed the low level of ATP11C mRNA in UPS-1 cells using three independent primer sets (Figures 2A and 4E ). By contrast, the mRNA levels of ATP11A and CDC50A were comparable between UPS-1 and CHO cells (Figure 2A) . We also examined the mRNA levels of ATP11A, ATP11C, and CDC50A by quantitative RT-PCR. As shown in Figure 2B , the mRNA level of ATP11C was much lower in UPS-1 cells than in the parental CHO cells. By contrast, the ATP11A
and CDC50A mRNA levels in UPS-1 cells were comparable to those in CHO cells.
Next, we examined a possibility that the coding sequence of ATP11C is changed in UPS-1 cells. To this end, we cloned nine cDNA fragments for ATP11C from UPS-1, which altogether cover the entire coding sequence of ATP11C and its C-terminal splicing variant, and sequenced at least four independent clones for each fragment. Interestingly, we found a nonsense mutation heterogeneity has been observed in CHO cell lines (26, 27) , the raw data of direct sequencing of the chromosomal DNA showed a single peak at the mutation site ( Figure 2C ), indicating a homozygous mutation in the ATP11C gene. We cannot exclude a possibility that the locus of ATP11C gene in UPS-1 cells is hemizygous. These results indicate that the defect of PS-uptake in UPS-1 cells is caused by the lack of the functional ATP11C protein, although we could not examine the ATP11C protein level because an antibody, which can detect endogenous ATP11C in CHO cells, is not available.
The mutation site was located at 205 nucleotides upstream from the junction between exon 19 and exon 20 ( Figure 2C ). Nonsense-mediated mRNA decay (NMD) is a well-characterized posttranscriptional quality control mechanism to ensure transcription fidelity (28) . NMD can be activated when a nonsense codon appears over 50-55 nucleotides upstream from an exon-exon junction. Thus, in UPS-1 cells, the ATP11C mRNA might be degraded by the NMD mechanism and thus the level of ATP11C was dramatically reduced (Figure 2A and B).
We previously showed that expression of ATP11A and ATP11C in HeLa cells increases the PS-and PE-flipping activities, although the PE-flipping activity of ATP11C is lower than that of ATP11A (13) . Because PE-flipping activity was not significantly affected in UPS-1 cells ( Figure   1A and B), ATP11C is primarily responsible for PS-flipping in CHO cells. The residual PSflipping activity observed in UPS-1 cells might be due to the presence of ATP11A, or other flipping activities ( Figure 1A ). ATP11C appears to be a critical protein for PS-flipping at the plasma membrane in multiple cell types; 1) some phenotypes of the ATP11C mutant mice cannot be suppressed by the presence of endogenous ATP11A (17,18) and 2) degradation of ATP11C by caspase is responsible for PS exposure to the outer leaflet of the plasma membrane in apoptotic cells (19) .
Exogenous expression of ATP11C complements the defect in PS-flipping activity in UPS-1 cells.
Next, we asked whether PS-flipping activity can be recovered by exogenous expression of ATP11C in UPS-1 cells. To this end, we expressed C-terminally HA-tagged ATP11C or its
ATPase-deficient Glu-to-Gln mutant (E184Q) (13) by infection of recombinant retrovirus, and subjected the infected cells to the flippase assay. ATP11C and the ATP11C(E184Q) mutant were expressed at comparable levels, as confirmed by immunoblot analysis ( Figure 3C ). By expressing ATP11C but not ATP11C(E184Q), the PS-flipping activity was significantly increased, relative to vector-infected UPS-1 cells ( Figure 3A and B), whereas the PE-flipping activity was not changed. When a UPS-1 cell line stably expressing ATP11C was examined (clone 16), PSflipping activity was approximating to that in parental CHO cells ( Figure 4A and B). We confirmed ATP11C expression in clone 16 by immunoblot analysis ( Figure 4C ) and its localization to the plasma membrane (PM) by immunofluorescence ( Figure 4D ). Thus, in CHO cells, ATP11C is crucial for PS-flipping, but not PE-flipping. Because there was a subtle, but significant, increase in the PE-flipping activity in stably ATP11C-expressing UPS-1 cells ( Figure   4A ), exogenous ATP11C may also flip NBD-PE as we described previously (13).
In order to exclude possible contamination of parental CHO cells in the ATP11C-expressing 
